Cohance Lifesciences Limited has informed the Exchange about Schedule of meet
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cohance Lifesciences (formerly Suven Pharmaceuticals) has informed the exchanges that its management will attend two investor roadshows in Hyderabad. The first is the GS India CRDMO Trip on June 18, 2025, and the second is the Jefferies India Healthcare & Pharma Trip on June 19, 2025. Both meetings will be held in a group format. The company clarified that no unpublished price-sensitive information will be shared during these interactions. The schedule is subject to change due to exigencies on the part of the analysts, investors, or the company.
This is a routine disclosure about investor engagement roadshows and is unlikely to move the stock. Investors may watch for any incremental commentary on the company's CRDMO (Contract Research, Development and Manufacturing) business, which is the focus of the GS roadshow.